Prokop Vodicka

7PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka

|Sep 08, 2025
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.

Prokop Vodicka, Iva Hamova, Adriana Velasova

|Mar 31, 2025
The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis.

Prokop Vodicka, Michal Masar, Katerina Benesova

|Mar 27, 2023
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).

Martin Špaček, Lukáš Smolej, Martin Šimkovič

|Dec 13, 2022
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options.

Prokop Vodicka, Pavel Klener, Marek Trneny

Pageof 2

Frequent Collaborators

3 joint publications

Marek Trneny

2 joint publications

Matthew J Maurer

2 joint publications

Pavel Klener

2 joint publications

James R Cerhan